Senior Analyst, Investor Relations & Business Development (Artificial Intelligence Enablement)
Integra LifeSciences
Summary
The Senior Analyst, Investor Relations & Business Development will help develop artificial intelligence-enabled capabilities across both functions. The role combines strong financial and strategic analysis with practical application of artificial intelligence to improve how information is gathered, connected, analyzed and used to support business decisions. This individual will partner with Investor Relations and Business Development leadership to improve market intelligence, investor insights, strategic analysis, opportunity screening and due diligence. The role will also help build repeatable processes that improve the speed, quality and depth of work across both functions.
Job description
Investor Relations Artificial Intelligence Enablement
- Investor and analyst sentiment: Integrate investor feedback, analyst research, consensus estimates, valuation, peer performance and competitive developments to provide a more complete and timely view of external expectations and changes in sentiment.
- External expectations and internal plans: Connect market expectations with financial models, strategic plans and current year operating plans to identify potential gaps between what investors expect and what internal plans and capabilities support.
- Messaging and expectation setting: Bring together external sentiment, internal performance expectations and strategic priorities to identify evolving investor questions, pressure points, areas requiring greater clarity and proof points that can strengthen the investment story.
- Investor targeting and engagement: Improve the identification and prioritization of current and prospective investors for conferences, roadshows and other outreach based on ownership, investment profile, areas of interest and fit with the Integra investment story.
- Earnings and investor preparation: Improve earnings preparation, question and answer development, investor and analyst meeting preparation, peer analysis, consensus tracking and post earnings analysis.
- Investor Relations knowledge and process efficiency: Improve access to and analysis of historical messaging, question and answer materials, investor feedback and market intelligence while identifying recurring work that can be simplified, automated or performed more effectively.
Business Development Artificial Intelligence Enablement
- Early stage opportunity screening: Rapidly synthesize company, market, competitive, technology and available financial information to support faster initial assessments of strategic fit and attractiveness.
- Offering memorandum analysis: Develop repeatable approaches to review and synthesize offering memorandums and other transaction materials, surfacing the financial, commercial, market and strategic information most relevant to an initial assessment.
- Data site and diligence analysis: Improve the processing and analysis of large volumes of diligence information to identify relevant findings, inconsistencies, open questions and areas requiring deeper review.
- Market and competitive intelligence: Improve market landscaping, competitive analysis and strategic research supporting potential opportunities.
- Financial and valuation analysis: Combine artificial intelligence capabilities with traditional financial analysis to improve the speed and depth of opportunity assessment and valuation work.
- Strategic monitoring: Develop more effective ways to monitor companies, technologies, markets and other areas of strategic interest.
- Business Development process efficiency: Identify recurring activities that can be simplified or automated and develop repeatable capabilities that reduce manual work and allow the team to evaluate opportunities more efficiently.
Shared Responsibilities
- Apply strong financial, analytical and business judgment when developing and using artificial intelligence-enabled capabilities.
- Independently validate artificial intelligence-generated information and analysis before it is incorporated into business recommendations or decision support.
- Stay current on emerging artificial intelligence capabilities and identify practical applications relevant to Investor Relations and Business Development.
- Partner across both functions to develop repeatable processes that improve the quality, speed and usefulness of analysis.
- Protect confidential, financial and transaction information and follow applicable company policies when using artificial intelligence tools.
Requirements
- Bachelor's degree in Finance, Accounting, Economics, Business, Data Analytics, Engineering or a related field
- A minimum of 4 years of relevant experience in finance, investment banking, equity research, corporate development, strategy, consulting or another analytically rigorous business role
- Demonstrated experience applying artificial intelligence to financial, strategic or business problems beyond basic drafting, research and summarization
- Strong financial and quantitative skills, including experience with financial modeling and valuation
- Ability to synthesize complex financial, market and strategic information and translate it into clear, actionable insights
- Strong judgment, including the ability to challenge assumptions, identify unreliable information and independently validate analytical conclusions
- Demonstrated curiosity and a process improvement mindset, with an interest in developing better ways to use information, technology and artificial intelligence
- Strong written and verbal communication skills
- Ability to manage priorities across two functions and work effectively with senior leaders and cross-functional partners
- Healthcare or medical technology experience preferred
- MBA or other advanced degree preferred but not required
Benefits
- Medical, Dental & Vision
- Life Insurance
- Short- & Long-Term Disability
- Business Accident Insurance
- Group Legal Insurance
- 401(k) Savings Plan
- Bonus/Equity Eligible
Company overview
Integra LifeSciences Holdings Corporation is a global medical technology company headquartered in Princeton, New Jersey, founded in 1989. As a publicly traded company on NASDAQ under the symbol IART, Integra specializes in developing and manufacturing innovative medical devices for neurosurgery, reconstructive surgery, and general surgery applications. The company is renowned for its pioneering work in regenerative medicine, most notably the Integra artificial skin, which was the first commercially reproducible skin tissue used to treat severe burns and other skin wounds. Integra's comprehensive product portfolio includes surgical instruments, neurosurgical devices, advanced wound care solutions, orthopedic hardware, dermal regeneration products, and tissue-engineered wound dressings. With approximately 3,946-4,396 employees worldwide, the company serves hospitals, outpatient surgery centers, and medical practices globally through direct sales representatives and an extensive distribution network. Integra's commitment to limiting uncertainty for surgeons enables healthcare professionals to focus on providing optimal patient care through simplified procedures and reliable medical technology solutions.